 Home > Active Ingredient News > Endocrine System > JAMA Netw Open: Impact of lifestyle interventions on preventing worsening of glycemic status in South Asian women with gestational diabetes mellitus

JAMA Netw Open: Impact of lifestyle interventions on preventing worsening of glycemic status in South Asian women with gestational diabetes mellitus

 Last Update: 2022-04-20
 Source: Internet
 Author: User

Tags

7 11 orlando

dwk life sciences

type 4 collagen

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Why it matters: Recent studies have shown that women with gestational diabetes mellitus (GDM) are at increased risk of developing type 2 diabetes

Women with gestational diabetes mellitus (GDM) are at increased risk of developing type 2 diabetes

Design, settings, and participants: This randomized, participant open-label controlled trial investigated a 12-month life>

Main outcomes and methods of measurement: The primary outcome was the classification of glycemic exacerbation according to the American Diabetes Association criteria OGTT: (1) normal glucose tolerance to prediabetes (ie, impaired fasting glucose or impaired glucose tolerance) or type 2 diabetes or (2) diabetes mellitus Pre-to-type 2 diabetes

RESULTS: A total of 1823 women (baseline mean [SD] age 30.

Figure 1 Kaplan-Meier plot of the main results

Table 1 Effects of the intervention on secondary outcomes

Conclusions: This study found that a majority of women in urban South Asian settings developed dysglycemia shortly after a GDM-affected pregnancy, and that life>

The study found that a large proportion of women in South Asian urban settings developed dysglycemia shortly after a GDM-affected pregnancy, and that life>

Effects of a Life>JAMA

Leave a Comment

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Factory Wholesale Retail Tirzepatide peptide CAS 2023788-19-2 FEI DUNS Tirezapitde

CAS No.: 2023788-19-2

Pharmacy Grade

$60.00/UNIT EXW

Factory Wholesale Retail Semaglutide API 0zempic and weg0ry CAS: 910463-68-2 Purity 99% Factory Supplier

CAS No.: 910463-68-2

Pharmacy Grade

$20-26/UNIT EXW

High Qulaity Dydrogesterone CAS 152-62-5 Pharmaceutical Grade White Powder

CAS No.: 152-62-5

Pharmacy Grade

$30-39/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.